Skip to main content

Table 3 Demographic patient data (age, BMI) and blood count (hemoglobin (Hb), platelet and leukocyte counts) of soft tissue sarcoma patients with and without a history of venous thromboembolism (VTE)

From: Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism

  G2 without a history of VTE (n = 5) G2 with history of VTE (n = 3) M1 without a history of VTE (n = 11) M1 with history of VTE (n = 8) All sarcoma patients without history of VTE (n = 28) All sarcoma patients with history of VTE (n = 11) Healthy controls (n = 17) p-value of G2 patients with VTE vs controls p-value of M1 patients with vs without VTE p-value of all patients with VTE vs without VTE
Age (years) 69.4 ± 10.7 54.3 ± 3.9 56.8 ± 10.3 52.13 ± 14.4 58.1 ± 12.6 52.7 ± 12.4 48 ± 10.0 0.3179 0.4426 0.2460
BMI (kg/m2) 25.5 ± 2.5 23.3 ± 3.2 24.4 ± 4.2 24.3 ± 4.8 24.7 ± 3.6 24.1 ± 4.4 24.2 ± 3.4 0.7287 0.9756 0.6577
Hb (g/dl) 13.5 ± 0.9 10.5 ± 2.7 11.6 ± 1.6 12.7 ± 1.8 12.8 ± 1.8 12 ± 2.4 14,63 ± 1.0 0.0003 0.2561 0.3167
Platelets (th/μl) 256.0 ± 16.5 401.0 ± 150.1 254.0 ± 123.3 354.9 ± 144.4 261.8 ± 98.3 368.7 ± 147.7 227.3 ± 45.5 0.0018 0.1554 0.0186
Leukocytes (th/μl) 6.3 ± 1.0 9.5 ± 3.3 7.8 ± 6.5 7.9 ± 3.6 7.3 ± 4.3 8.4 ± 3.6 5.8 ± 1.2 0.0032 0.9773 0.4848
  1. Data are presented as mean value ± standard deviation (SD). p-values were determined using Student’s t-tests for independent samples. p-values <0.05 are marked in bold